Tirzepatide users on hormone therapy had added improvements in weight, cardiometabolic mar ...

Learn how new oral GLP-1 weight loss pills work, how they compare with injections, and how the next generation of “small ...

As GLP-1 pills for weight loss enter the U.S. market, some pharmaceutical companies are testing the possibility of a gene therapy to stimulate GLP-1 production, The Washington Post reported Jan. 24.

GLP-1 receptor agonists increase hormones that help control hunger, satiety and blood sugar. They boost the release of insulin in the body when blood sugar rises, reduce glucagon (a hormone that ...

Clinical trials show retatrutide, Eli Lilly's new triple-agonist drug, delivered 24.2% weight loss in 48 weeks and the improvement of other conditions in longer studies.

Gene therapy for weight loss is being explored as a potential game-changer, with therapy aiming to program the body to ...

Consumers say that smaller doses of a popular weight-loss drug eased side effects and improved their health Telehealth ...

New fleet of weight loss drugs are more effective than the current popular obesity medications at trial - One in eight Americans are taking a GLP-1 drug, a recent poll found ...

LMNT reports that GLP-1 medications for obesity and diabetes may lead to electrolyte imbalances, highlighting hydration ...

At a high level these drugs mimic glucagon-like peptide-1, or GLP-1, a hormone our bodies naturally produce in the gut. When ...

Welcome to The Thin Line, The New York Post’s new series about the darker side of GLP-1 drugs. Though GLP-1 agonists sold ...